American Portfolios Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
CIP
EVM
CB
American Portfolios Advisors's IART Position: Q3 2022 in Review
American Portfolios Advisors sold out of Integra LifeSciences (IART) in Q3 2022, closing a stake of 296 shares — an estimated $16K sold.
American Portfolios Advisors first reported a position in IART in Q4 2017 and held it in 19 quarters. The position peaked at $32.4K in Q3 2019. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.
- American Portfolios Advisors reported no remaining Integra LifeSciences position as of Q3 2022 after selling out during the quarter.
- American Portfolios Advisors sold 296 Integra LifeSciences shares in Q3 2022, an estimated $16K.
- American Portfolios Advisors first reported a position in Integra LifeSciences in Q4 2017 and held it in 19 quarters.
- American Portfolios Advisors's Integra LifeSciences position peaked at $32.4K in Q3 2019.
- 282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.